Elevance Health, Inc. stock performance
How ELV has traded: the past year against the market, standard returns, where the price sits in its 52-week range, what it costs relative to earnings, and what it pays out.
The past year vs the market
Percent change in the closing price since Sep 4, 2025, excluding dividends.
Returns
| Period | ELV | S&P 500 |
|---|---|---|
| 1 month | +7.8% | -0.2% |
| 6 months | +39.8% | +12.4% |
| Year to date | +16.2% | +12.8% |
| 1 year | +32.3% | +18.7% |
Price returns to the close of Sep 4, 2026, excluding dividends. A period the history does not reach back into shows a dash rather than a shorter figure under the same label.
52-week range
ELV closed at $407.50 on Sep 4, 2026 — 4.5% below its 52-week high.
Valuation
| Market cap | $88.6B |
| Price to earnings (TTM) | 17.8× |
| Price to sales (TTM) | 0.4× |
The figures here mix sources on purpose: the market capitalization is market data as of Sep 4, 2026, divided by trailing-twelve-month net income and revenue from Elevance Health, Inc.'s filings with the SEC.
Dividends
Elevance Health, Inc. paid $6.86 per share over the trailing twelve months — a yield of 1.7% on the $407.50 close.
| Ex-dividend date | Per share |
|---|---|
| Jun 10, 2026 | $1.72 |
| Mar 10, 2026 | $1.72 |
| Dec 5, 2025 | $1.71 |
| Sep 10, 2025 | $1.71 |
Related
- ELV financial history: revenue, margins, and cash flow →
- Health insurers compared: ELV against its peers →
Share prices and dividends are market data — daily closing prices for the listing as traded, not figures from company filings. Returns are price returns and exclude dividends; past performance does not predict future results.